12
February 2025
Dr. Martens
plc
APPOINTMENT OF NON-EXECUTIVE
DIRECTORS
Dr. Martens plc ('the Company') is
pleased to announce the appointments of Robert Hanson and Benoit
Vauchy as Non-Executive Directors of the Company with effect from
26 March 2025.
Robert is an experienced executive
with a strong track record of delivering growth at consumer brands.
He was CEO of John Hardy and American Eagle Outfitters and also
served as EVP Wines and Spirits for Constellation Brands. Prior to
this he served for over a decade in senior roles at Levi Strauss
& Co, including as President of the Americas division and,
latterly, as Global Brand President, Americas. Robert brings a
broad, multidisciplinary skillset and significant experience of the
North American market combined with global expertise. His prior
non-executive experience includes positions on the boards of Canopy
Growth, Urban Outfitters and Constellation Brands. He was recently
appointed as CEO of US wine company The Duckhorn
Portfolio.
Benoit is a Partner at the Company's
largest investor, global investment firm Permira, where he is a
member of the Investment and Executive Committees. He has served on
the board of Spanish online travel company eDreams ODIGEO as a
Non-Executive Director for a decade, during which time the business
has undergone a significant period of transformation. Benoit also
serves on the board of Permira Holdings Limited and has previously
served on the boards of Universidad Europea, VacanceSelect and
Exclusive Networks. He has worked at Permira since 2006, and
previously spent six years at JPMorgan in London and
Frankfurt.
Paul Mason, Chairman, said: "We are
pleased to announce these appointments today. The expertise and
experiences of both Robert and Benoit further strengthens our
Board. Robert has significant USA and wholesale experience and is a
proven consumer brand CEO. Benoit is an experienced financial
leader and his appointment to the Board demonstrates Permira's
commitment to Dr. Martens. I am looking forward to working with
them both, together with the existing Board, as we enter the next
phase in the company's history, under the talented leadership of
Ije and Giles."
NOTES
1. This announcement
is made pursuant to UK Listing Rule 6.4.6R.
2. On joining the Board,
Robert will be considered as independent and will also become a
member of the Nomination Committee.
3. The Company confirms
that there is no further information that is required to be
disclosed pursuant to UK Listing Rule 6.4.8R.
Enquiries
Investors and analysts
Bethany Barnes, Director of Investor
Relations
Bethany.Barnes@drmartens.com
+44 7825 187465
Beth Fionda, Investor Relations
Manager
Beth.Fionda@drmartens.com
Press
H/Advisors Maitland
+44 20 7379 5151
Katharine Spence
+44 7384 535739
Gill Hammond, Director of
Communications
+44 7384
214248
About Dr. Martens
Dr. Martens is an iconic British
brand founded in 1960 in Northamptonshire. Produced originally for
workers looking for tough, durable boots, the brand was quickly
adopted by diverse youth subcultures and associated musical
movements. Dr. Martens has since transcended its working-class
roots while still celebrating its proud heritage and, six decades
later, "Docs" or "DM's" are worn by people around the world who use
them as a symbol of empowerment and their own individual attitude.
The Company listed on the main market of the London Stock Exchange
on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250
index.
